World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 20 August 2018
Main ID:  ACTRN12618000257268
Date of registration: 16/02/2018
Prospective Registration: Yes
Primary sponsor: Deakin University
Public title: Episodic Future Thinking for Positive Events: Enhancing Anticipated Pleasure in Depression
Scientific title: Episodic Future Thinking for Positive Events: Enhancing Anticipated Pleasure in Depression
Date of first enrolment: 18/07/2018
Target sample size: 10
Recruitment status: Not yet recruiting
URL:  http://www.anzctr.org.au/ACTRN12618000257268.aspx
Study type:  Interventional
Study design:  Non-randomised trial  Single group
Phase:  Not Applicable
Countries of recruitment
Contacts
Key inclusion & exclusion criteria
Health Condition(s) or Problem(s) studied
Depression
Intervention(s)
Participants will be recruited from inpatient and outpatient settings at the adult mental health service of the National Institute for Mental Health and Neurosciences, Bengaluru, India.
The intervention will consist of a series of brief questions asking participants to provide some detail about the upcoming positive events they anticipate might happen (e.g., what will happen, who will be there, how will you feel, have you enjoyed this before). The intervention is designed to stimulate episodic future thinking about the upcoming event in order to increase anticipated pleasure. This will be implemented as part of monitoring of activity over a 14 day period for depressed individuals recruited from an adult mental health service.

After providing informed consent participants will be randomised to a Phase B start-point, which will be after a minimum of 30 Phase A observations (6 days). Phase B will commence, at the latest, after 55 observations (11 days), and therefore last a minimum of 15 observations (3 days). The actual start-point, and therefore the length of the respective phases, will be randomly determined. Participants will be asked to engage in monitoring of their activity over the 14 days, and over this period, dependent on what start-point they were randomized to, they will switch from Phase A to Phase B.

Participants will receive email links to online surveys 5 times per day (8:30am, 11:30am, 2pm, 4:30pm, and 7pm). Each survey will ask them to indicate what activity they are most looking forward to in the next 2 hours. They will choose from a list of options for each activity (e.g., work/school/study, media/tv/internet, and conversation/socialising, specified other). Participants will then complete a brief series of questions relating to the upcoming positive activity, including how vivid their mental image was, how easy it was to think of the activity, how pleasurable they think it will be, their intention to engage in it, and their current affect. At each prompt they will be also be asked whether or not they engaged in the previously nominated activity, and how enjoyable it was. The surveys are expected to take 3-5 minutes to complete, and the future thinking task approximately 2-4 minutes.

-In Phase A, participants will complete the surveys
-In Phase B, participants will complete these surveys, and also engage in a future thinking task after they nominate the upcoming positive activity. This task will involve mentally simulating the positive activity through a series of online written prompts as part of the survey, and including questions such as 'who will be there', 'what will happen', 'why might you enjoy it', 'what emotion might you feel' etc.

All participants will start in Phase A and then switch to Phase B at some point.

If participants fail to complete several surveys in a row they will be contacted with a phone call to assess for any complicating factors in adherence.

At the cessation of Phase B, the participants will receive evidence-based treatment for depression as per NIMHANS usual care protocols.
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history